Christine E. Hamilton - Jul 15, 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Christine E. Hamilton
Stock symbol
SABS
Transactions as of
Jul 15, 2024
Transactions value $
$0
Form type
4
Date filed
7/17/2024, 04:30 PM
Previous filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Stock Option (right to buy) Award $0 +20K $0.00 20K Jul 15, 2024 Common Stock 20K $2.90 Direct F1, F6
transaction SABS Stock Option (right to buy) Award $0 +5.82K $0.00 5.82K Jul 15, 2024 Common Stock 5.82K $5.40 Direct F2, F6
transaction SABS Stock Option (right to buy) Award $0 +4.45K $0.00 4.45K Jul 15, 2024 Common Stock 4.45K $2.90 Direct F3, F6
transaction SABS Stock Option (right to buy) Award $0 +44.2K $0.00 44.2K Jul 15, 2024 Common Stock 44.2K $5.40 By Spouse. F4, F6
transaction SABS Stock Option (right to buy) Award $0 +2.33K $0.00 2.33K Jul 15, 2024 Common Stock 2.33K $2.90 By Spouse. F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026.
F2 Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option are fully vested.
F3 Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest in three equal annual installments on July 15, 2025, 2026, and 2027.
F4 Represents a one-time grant to the Reporting Person's spouse as an advisor to the Board. Shares underlying the option are fully vested.
F5 Represents a one-time grant to the Reporting Person's spouse as an advisor to the Board. Shares underlying the option vest in three equal annual installments on July 15, 2025, 2026, and 2027.
F6 This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.